AGER and breast cancer: In accordance with these findings and taking into consideration the pro-invasive action of both RAGE and EphA3 in BC [30, 106], we have also demonstrated that RAGE overexpression facilitates a migratory and invasive phenotype through the activation of the Ephrin B2/EphA3 signaling in ER-positive BC cells.